{"id":"W4408502164","doi":"10.1038/s43018-025-00921-6","title":"Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial","year":2025,"lang":"en","type":"article","venue":"Nature Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; University of Alberta","funders":"Regeneron Pharmaceuticals","keywords":"Refractory (planetary science); Medicine; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Lymphoma; Phases of clinical research; Clinical trial; Primary (astronomy); Materials science; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001203315,0.0007243414,0.001222735,0.0002126222,0.0001571197,0.000609469,0.0003787592,0.0005245471,0.001571043],"category_scores_gemma":[0.0004783616,0.0002141957,0.0006214177,0.0002043936,0.0003154787,0.0005177332,0.000254418,0.001180791,0.0003649355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004798357,"about_ca_system_score_gemma":0.000449574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002137561,"about_ca_topic_score_gemma":0.0008855006,"domain_scores_codex":[0.999728,0.0001486523,0.00001447265,0.00003896902,0.00002697962,0.00004302491],"domain_scores_gemma":[0.9997844,0.000039374,0.00005036108,0.00001840396,0.00001259722,0.00009480311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6860933,0.02326324,0.0208266,0.001423962,0.001869123,0.0006896452,0.0003561469,0.003213695,0.05897031,0.0003343342,0.004879487,0.1980802],"study_design_scores_gemma":[0.5757992,0.3534017,0.05078781,0.0001187527,0.000821915,0.001060549,0.0001077969,0.003566638,0.006740195,0.0003783455,0.007167859,0.00004930653],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956814,0.002305421,0.0001909586,0.0001409276,0.00002997396,0.0003436599,0.0004316502,0.00004055117,0.0008354608],"genre_scores_gemma":[0.9941685,0.001450602,0.000600122,0.0005103842,0.00009288291,0.0005250783,0.001566713,0.00001198102,0.00107368],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001571043,"threshold_uncertainty_score":0.006363809,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006223594720564041,"score_gpt":0.3084274952527611,"score_spread":0.3022039005321971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}